Literature DB >> 22429872

Citalopram is a more potent platelet function inhibitor than paroxetine in a case-control study.

T C Van Holten, M Roest, J Riphagen, C Jansen, P Naarding, H J Adriaansen, P G De Groot, J A Remijn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22429872     DOI： 10.1111/j.1538-7836.2012.04703.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  4 in total

1.  Platelet Activation Test in Unprocessed Blood (Pac-t-UB) to Monitor Platelet Concentrates and Whole Blood of Thrombocytopenic Patients.

Authors:  Mark Roest; Thijs C van Holten; Ger-Jan Fleurke; Jasper A Remijn
Journal:  Transfus Med Hemother       Date:  2013-03-28       Impact factor: 3.747

2.  Baseline Platelet Activation and Reactivity in Patients with Critical Limb Ischemia.

Authors:  Peter Paul Wisman; Martin Teraa; Gert Jan de Borst; Marianne C Verhaar; Mark Roest; Frans L Moll
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

3.  Increased platelet reactivity is associated with circulating platelet-monocyte complexes and macrophages in human atherosclerotic plaques.

Authors:  Bert Rutten; Claudia Tersteeg; Joyce E P Vrijenhoek; Thijs C van Holten; Ellen H A M Elsenberg; Elske M Mak-Nienhuis; Gert Jan de Borst; J Wouter Jukema; Nico H J Pijls; Johannes Waltenberger; Anton Jan van Zonneveld; Frans L Moll; Elizabeth McClellan; Andrew Stubbs; Gerard Pasterkamp; Imo Hoefer; Philip G de Groot; Mark Roest
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

Review 4.  The Human Carbonic Anhydrase II in Platelets: An Underestimated Field of Its Activity.

Authors:  Maciej Jakubowski; Ewa Szahidewicz-Krupska; Adrian Doroszko
Journal:  Biomed Res Int       Date:  2018-06-28       Impact factor: 3.411
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.